(Q51082984)

29 March 2018

title

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. (English)

1 reference

29 March 2018

0 references

Gerra G

1

1 reference

29 March 2018

Zaimovic A

2

1 reference

29 March 2018

Ferri M

3

1 reference

29 March 2018

Zambelli U

4

1 reference

29 March 2018

Timpano M

5

1 reference

29 March 2018

Neri E

6

1 reference

29 March 2018

Marzocchi GF

7

1 reference

29 March 2018

Delsignore R

8

1 reference

29 March 2018

Brambilla F

9

1 reference

29 March 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

29 March 2018

published in

Biological Psychiatry

1 reference

29 March 2018

volume

47

1 reference

29 March 2018

issue

2

1 reference

29 March 2018

page(s)

127-136

1 reference

29 March 2018

Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Memory impairment in abstinent MDMA ("Ecstasy") users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

A systematic method for clinical description and classification of personality variants. A proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Subjective reports of the effects of MDMA in a clinical setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

HPA-Axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: an [15O]H2O PET study in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Neurotoxicity of MDMA and related compounds: anatomic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

An inventory for assessing different kinds of hostility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900180-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00180-8

1 reference

29 March 2018

1 reference

29 March 2018